Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!


Planet 13 Announces Full Year 2019 Financial Results and Q1 2020 Revenue

Financial Highlights – Q4 – 2019

Operating Results

All comparisons below are to the quarter ended December 31, 2018, unless otherwise noted

  • Revenues were $16.5 million as compared to $8.3 million, an increase of 99.8%
  • Gross profit before biological adjustments was $9.4 million or 57.1% as compared $4.2 million or 50.5%, an increase of 125.8%
  • Operating expenses, excluding non-cash compensation expense, were $7.1 million as compared to $5.8 million, an increase of 21.5%
  • Net loss before taxes of $0.9 million as compared to a net loss of $2.2 million
  • Net loss of $2.6 million as compared to a net loss of $3.1 million
  • Adjusted EBITDA of $2.5 million as compared to Adjusted EBITDA loss of $1.5 million

Planet 13 Announces Full Year 2019 Financial Results and Q1 2020 RevenueLAS VEGAS, April 14, 2020 /CNW/ – Planet 13 Holdings Inc. (CSE: PLTH) (OTCQB: PLNHF(“Planet 13” or the “Company“), a leading vertically-integrated Nevada cannabis company, today announced financial results for the three-month and twelve-month periods ended December 31, 2019. Planet 13’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).

Larry Scheffler, Co-CEO of Planet 13 commented, “Over the past month, businesses across the country have had to quickly adjust to the reality of COVID-19 related restrictions, and Planet 13 has been no exception. While this has impacted our day to day operations, we are approaching this challenge as an opportunity to deliver safe and responsible cannabis to our community. When cannabis dispensaries in Nevada were told to close, we pivoted to focus on our delivery business, and in only 25 days we’ve ramped our delivery service from five to twenty-eight vehicles and have shifted our customer mix from 15% local area residents, to 100%.”

Mr. Scheffler continued, “While tourism will continue to be a strong driver of our business when things return to normal, this is a unique opportunity for us to build a strong local base and gain lasting market share as we become a fixture in the daily lives of Las Vegas Valley residents.

Bob Groesbeck, Co-CEO added, “We opened Phase II of the SuperStore during Q4 and are pleased to report that as projected, it drove increased traffic, customer engagement, and higher average ticket. Through Q4, a seasonally slow period, we delivered $16.5 million in revenue. During Q1 2020, we saw the network effect of Phase II accelerate, resulting in ~$16.6 million in revenue, a 20% increase compared to Q1 of 2019, despite effects of COVID-19 starting in the middle of March. In addition, the customer-facing production facility is fully ramped up and we have begun to offer Planet 13’s portfolio of in-house brands to select third-party dispensaries on a wholesale basis.”

 

Best Marijuana Stocks 2020

  • 2019 Revenue of $63.6 million
  • SuperStore accounted for 9.1% of all Nevada cannabis dispensary revenue in 20191
  • 2019 EBITDA of $9.9 million
  • Q1 2020 Revenue of $16.6 million

All figures are reported in United States dollars ($) unless otherwise indicated

Balance Sheet

All comparisons below are to December 31, 2018, unless otherwise noted

  • Cash of $12.8 million as compared to $19.4 million
  • Total assets of $62.9 million as compared to $44.9 million
  • Total liabilities of $21.6 million as compared to $7.0 million

Financial Highlights – Full Year – 2019

All comparisons below are to the year ended December 31, 2018, unless otherwise noted

  • Revenues were $63.6 million as compared to $21.2 million, an increase of 200.4%
  • Gross profit before biological adjustments was $36.5 million or 57.3% as compared $10.7 million or 50.4%, an increase of 242.0%
  • Operating expenses, excluding non-cash compensation expense, were $26.8 million as compared to $11.3 million, an increase of 137.5%
  • Net income before taxes of $0.5 million as compared to a net loss of $8.4 million
  • Net loss of $6.7 million as compared to a net loss of $10.7 million
  • Adjusted EBITDA of $9.9 million as compared to Adjusted EBITDA loss of $367,874

Q4 Highlights and Recent Developments

For a more comprehensive overview of these highlights and recent developments, please refer to Planet 13’s Management’s Discussion and Analysis of the Financial Condition and Results of Operations for the Three and Twelve Months Ended December 31, 2019 (the “MD&A“).

  • On November 1, 2019, Planet 13 announced the opening of the customer-facing production facility.
  • On December 16, 2019, Planet 13 announced winning U.S. Market Leader Award in Retail at MJBizCon.
  • On January 20, 2020, Planet 13 announced the opening of dosist™ shop-in-shop wellness experience.
  • On March 19, 2020, Planet 13 announced offering expanded online ordering and delivery services.
  • On March 23, 2020, Planet 13 announced 24-hour delivery service.
  • On April 13, 2020, Planet 13 announced termination of Santa Ana acquisition.

Results of Operations (Summary)

The following tables set forth consolidated statements of financial information for the three-month and twelve-month period ending December 31, 2019 and December 31, 2018. For further information regarding the Company’s financial results for these periods, please refer to the Company’s interim financial statements for the period ended December 31, 2019 together with the MD&A, available on Planet 13’s issuer profile on SEDAR at www.sedar.com and the Company’s website https://www.planet13holdings.com.

Adjusted EBITDA

NV Cannabis Ops Consolidated NV Cannabis Ops Consolidated
Three Months Three Months Three Months Year Year Year
Ended Ended Ended Percentage Ended Ended Ended Percentage
Dec-31-2019 Dec-31-2019 Dec-31-2018 Change Dec-31-2019 Dec-31-2019 Dec-31-2018 Change
EBITDA
Profit (loss) before taxes 1,416,699 (914,960) (2,215,973) (58.7%) 8,422,424 542,664 (8,433,501) (106.4%)
Add back:
   Biological asset adjustments 351,080 351,080 (108,084) (424.8%) 480,181 480,181 (192,908) (348.9%)
   Non-cash share based payments 1,694,370 367,497 361.1% 4,822,787 2,601,233 85.4%
   Depreciation and amortization 900,278 900,278 332,925 170.4% 2,845,464 2,845,464 400,116 611.2%
   Depreciation included in COGS 157,030 157,030 141,205 11.2% 286,987 286,987 258,788 10.9%
   Interest and non-operating expense (income) 329,291 329,291 (24,928) (1421.0%) 954,960 954,960 4,998,398 (80.9%)
EBITDA 3,154,378 2,517,089 (1,507,358) 267.0% 12,990,016 9,933,043 (367,874) 2800.1%
 Margin 19.1% 15.2% (18.2%) 20.4% 15.6% (1.7%)

 

Expressed in USD$ Three

Months

Three

Months

Year Year
Ended Ended Percentage Ended Ended Percentage
Dec-31-2019 Dec-31-2018 Change Dec-31-2019 Dec-31-2018 Change
Revenue
Revenues, net of discounts 16,540,324 8,279,698 99.8% 63,595,036 21,166,755 200.4%
Cost of Goods Sold (7,098,908) (4,097,973) 73.2% (27,139,658) (10,507,200) 158.3%
Gross Profit, Before Biological Asset Adjustment 9,441,416 4,181,725 125.8% 36,455,378 10,659,555 242.0%
Gross Profit Margin % 57.1% 50.5% 57.3% 50.4%
Realized fair value amounts included in COGS (695,361) 207,865 (434.5%) (1,500,965) (1,726,685) (13.1%)
Unrealized fair value gain on growth of biological assets 344,281 (99,781) (445.0%) 1,020,784 1,919,593 (46.8%)
Gross profit 9,090,336 4,289,809 111.9% 35,975,197 10,852,463 231.5%
Gross Profit Margin % 55.0% 51.8% 56.6% 51.3%
Expenses
General and Administrative 5,351,056 4,682,652 14.3% 20,269,839 9,583,376 111.5%
Sales and Marketing 1,730,301 1,147,636 50.8% 6,539,483 1,702,841 284.0%
Depreciation and Amortization 900,278 332,925 170.4% 2,845,464 400,116 611.2%
Share based payments 1,694,370 367,497 361.1% 4,822,787 2,601,233 85.4%
Total Expenses 9,676,005 6,530,710 48.2% 34,477,573 14,287,566 141.3%
Income (Loss) From Operations  (585,669) (2,240,901) (73.9%) 1,497,624 (3,435,103) (143.6%)
Other (Income) Expense:
Interest Expense, net 404,332 5,674 7026.0% 1,306,876 241,860 440.3%
Realized Foreign Exchange gain (loss) (4,376) (100.0%) (1,141) 37,879 (103.0%)
RTO acquisition costs na 4,702,604 na
Other expense (income) (75,041) (26,226) 186.1% (350,775) (80,285) 336.9%
Loss on settlement of accounts payable (Note 13(d)) na 96,340 na
Total Other Expense (Income) 329,291 (24,928) (1421.0%) 954,960 4,998,398 (80.9%)
Income (loss) for the period before tax (914,960) (2,215,973) (58.7%) 542,664 (8,433,501) (106.4%)
Provision for income tax (current and deferred) 1,662,213 889,066 87.0% 7,200,997 2,290,203 214.4%
(Loss) for the period (2,577,173) (3,105,039) (17.0%) (6,658,333) (10,723,704) (37.9%)
Other Comprehensive Income (Loss)
Items that may be reclassified subsequently to profit/loss 
     Foreign exchange translation adjustment (24,607) (666,969) 195,213 (802,920)
Net Comprehensive (Loss) for the period (2,601,780) (3,772,008) (6,463,120) (11,526,624)
(Loss) per share for the period
Basic and fully diluted loss per share ($0.02) ($0.02) ($0.05) ($0.11)
Weighted Average Number of Shares Outstanding
Basic and fully diluted 135,888,982 128,166,081 134,074,476 95,997,827

 

Planet 13 Announces 2019 Financial Results

Outstanding Shares

As at the date of this report, the Company had 84,451,832 common shares and 55,232,940 class A convertible, restricted voting shares issued and outstanding for a total of 139,684,772 shares outstanding.  There were 558,507 options issued and outstanding of which 250,834 have fully vested.  There were 13,572,238 warrants outstanding and 3,454,589 RSU’s outstanding of which nil RSUs had fully vested as at the date of this report.

Conference Call

Planet 13 will host a conference call on Tuesday, April 14, 2020 at 5:00 p.m. EST to discuss its third quarter financial results and provide investors with key business highlights.  The call will be chaired by Bob Groesbeck, Co-CEO, Larry Scheffler, Co-CEO, and Dennis Logan, CFO.

CONFERENCE CALL DETAILS

Date: April 14, 2020 | Time: 5:00 p.m. EST
Participant Dial-in: 416-764-8688 or 1-888-390-0546
Replay Dial-in: 416-764-8677 or 1-888-390-0541
(Available for 2 weeks)
Reference Number: 656850
Listen to webcast: https://bit.ly/3dUnQs2

Financial Measures

There are measures included in this news release that do not have a standardized meaning under generally accepted accounting principles (GAAP) and therefore may not be comparable to similarly titled measures and metrics presented by other publicly traded companies. The Company includes these measures because it believes certain investors use these measures and metrics as a means of assessing financial performance. EBITDA (earnings before interest, taxes, depreciation and amortization) is calculated as net earnings before finance costs (net of finance income), income tax expense, and depreciation and amortization of intangibles and is a non-GAAP financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies.

About Planet 13
Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas – the entertainment capital of the world. Planet 13’s mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13’s shares trade on the Canadian Stock Exchange (CSE) under the symbol PLTH and OTCQX under the symbol PLNHF.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking statements relate to, among other things, future expansion plans.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada and California cannabis markets and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the States of Nevada and California; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through its subsidiary MM Development Company, Inc. (“MMDC”) in Nevada. Local state laws where MMDC operates permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company’s business are contained under the heading “Risk Factors” in the Company’s annual information form dated April 30, 2019 filed on its issuer profile on SEDAR at www.sedar.com.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Expressed in United States Dollars As at As at
December 31, December 31,
2019 2018
Assets
Current Assets
Cash $ 12,814,712 $ 19,364,086
HST receivable 16,544 101,831
Inventories 5,474,004 5,322,111
Biological assets 514,526 915,177
Prepaid expenses and other current assets 3,694,272 1,391,278
Total Current Assets 22,514,058 27,094,483
Property and equipment 30,211,154 17,256,484
Right of use assets 9,478,733
Long-term deposits and other assets 694,601 594,339
40,384,488 17,850,823
Total Assets $ 62,898,546 $ 44,945,306
Liabilities
Current Liabilities
Accounts payable $ 864,260 $ 1,720,721
Accrued expenses 1,910,046 1,306,145
Income taxes payable 7,015,606 2,187,109
Notes payable – current portion 884,000 884,000
Current portion of lease liabilities 14,459
Total Current Liabilities 10,673,912 6,112,434
Long -term lease liabilities 10,522,377 29,768
Deferred rent 427,508
Other long-term liabilities 28,000
Deferred tax liability 379,665 470,856
10,930,042 928,132
Total Liabilities 21,603,954 7,040,566
Shareholders’ Equity
Share capital 51,986,849 42,460,824
Restricted share units 4,119,485 2,800,335
Warrants 5,961,091 7,046,843
Option reserve 399,439 305,890
Accumulated other comprehensive loss (607,707) (802,920)
Deficit (20,564,565) (13,906,232)
Total Shareholders’ Equity 41,294,592 37,904,740
Total Liabilities and Shareholders’ Equity $ 62,898,546 $ 44,945,306

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSSAND COMPREHENSIVE INCOME (LOSS)

Expressed in United States Dollars Year Year Three months Three months
Ended Ended Ended Ended
December 31, December 31, December 31, December 31,
2019 2018 2019 2018
Revenue
Revenues, net of discounts $ 63,595,036 $ 21,166,755 $ 16,540,324 $ 8,279,698
Cost of Goods Sold (27,139,658) (10,507,200) (7,098,908) (4,097,973)
Gross Profit before fair value asset adjustment 36,455,378 10,659,555 9,441,416 4,181,725
Realized fair value amounts included in inventory sold (1,500,965) (1,726,685) (695,361) 207,865
Unrealized fair value gain on growth of biological assets 1,020,784 1,919,593 344,281 (99,781)
Gross Profit 35,975,197 10,852,463 9,090,336 4,289,809
Expenses
General and Administrative 20,269,839 9,583,376 5,351,056 4,682,652
Sales and Marketing 6,539,483 1,702,841 1,730,301 1,147,636
Depreciation and Amortization 2,845,464 400,116 900,278 332,925
Share-Based Compensation Expense 4,822,787 2,601,233 1,694,370 367,497
Total Expenses 34,477,573 14,287,566 9,676,005 6,530,710
Income (Loss) From Operations  1,497,624 (3,435,103) (585,669) (2,240,901)
Other Expense:
Interest expense, net 1,306,876 241,860 404,332 5,674
Realized foreign exchange (gain) loss (1,141) 37,879 (4,376)
Other income (350,775) (80,285) (75,041) (26,226)
RTO listing expense 4,702,604
Loss on settlement of accounts payable 96,340
Total Other Expense 954,960 4,998,398 329,291 (24,928)
Income (Loss) before income taxes 542,664 (8,433,501) (914,960) (2,215,973)
Provision for tax – current 7,292,188 2,198,295 1,402,227 909,107
Provision for tax – deferred (91,191) 91,908 259,986 (20,041)
Net (loss) for the Year $ (6,658,333) $ (10,723,704) $ (2,577,173) $ (3,105,039)
Other Comprehensive Income (Loss)
     Foreign exchange translation gain (loss) 195,213 (802,920) (24,607) (666,969)
Net Comprehensive  (Loss) for the Year $ (6,463,120) $ (11,526,624) $ (2,601,780) $ (3,772,008)
Loss per share for the Year
Basic and diluted loss per share ($0.05) ($0.11) ($0.02) ($0.02)
Weighted Average Number of Common Shares Outstanding
Basic and Diluted (Note 17) 134,074,476 95,997,827 135,888,982 128,166,081

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Expressed in United States Dollars Year Year
Ended Ended
December 31, December 31,
2019 2018
Operating activities
Net (loss) for the year $ (6,658,333) $ (10,723,704)
Add (deduct) non-cash items:
Share based payments 4,822,787 2,601,233
Depreciation and amortization 3,607,286 988,768
  Write-off of fixed assets duringthe year 82,882
Loss on settlement of accounts payable 96,340
Share base payment to Carpincho shareholders on RTO 4,040,637
Deferred tax liability (91,191) 91,908
Realized foreign exchange (gain) loss 37,879
Interst on lease  liabilities 1,367,759
Non-cash interest expense 217,048
Net change in non-cash working capital
HST receivable 85,287 (101,831)
Inventories (151,893) (3,618,283)
Biological assets 400,651 152,129
Prepaid expenses and other assets (2,426,866) (1,299,148)
Long term deposits and other assets (100,262) (594,339)
Accounts payable (856,462) 798,672
Accrued expenses 603,902 250,318
Income tax payable 4,828,497 927,433
Other liabilities 28,000 427,508
Cash flow provided by (used in) operating activities 5,542,044 (5,707,432)
Investing activities
Net cash acquired on acquisition 34,678
Purchase of property, plant and equipment (16,061,582) (13,313,401)
Cash flow used in investing activities (16,061,582) (13,278,723)
Financing activities
Issuance of common shares and warrants 40,381,022
Issuance of shares on warrant and option exercises 5,030,185 2,374,253
Share and warrant issuance costs (4,032,025)
Principal and interest payment on lease liabilities (1,247,546) (11,845)
Cash flow provided by financing activities 3,782,639 38,711,405
Net increase (decrease) in cash  (6,736,899) 19,725,250
Cash  at beginning of the year 19,364,086 451,869
Effect of foreign exchange on cash 187,525 (813,033)
Cash at end of the year $ 12,814,712 $ 19,364,086

 

SOURCE Planet 13 Holdings Inc.

For further information: For further inquiries, please contact: LodeRock Advisors Inc., Planet 13 Investor Relations, mark.kuindersma@loderockadvisors.com, (416) 519-2156 ext. 2230; Robert Groesbeck or Larry Scheffler, Co-Chief Executive Officers, ir@planet13lasvegas.com
Planet 13 Announces 2019 Financial Results

About Cannin: Cannabis and Hemp Investment Experts

Market analysts expect the cannabis and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in cannabis and hemp stocks is now. Are you looking to buy stock in hemp companies or cannabis companies? Interested in emerging penny pot stock companies? Looking for the best Canadian pot company to invest in? Cannin is your trusted resource for information about Cannabis and Hemp stock investment opportunities. Our global team of experts evaluates emerging cannabis and hemp companies. We aggregate hundreds of hours of research and provide tips on the best cannabis and hemp stock investments for 2020. We provide the latest marijuana and hemp investment news and analysis. Visit our site for breaking cannabis investing news and featured companies, sign up for the free Cannin Chronicle or get a free trial of our smart cannabis and hemp stock algorithm to take the guesswork out of profiting from this exciting industry. Predict the price of cannabis and hemp stocks hours in advance with our proven machine learning algorithm. Is it too late to invest in marijuana stocks like Planet 13 Holdings? No! This is the perfect time to invest.

Profit from the best Cannabis and Hemp stocks – we’ll show you how at cannin.com